Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Nashville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of TYRA-300 in cancers with FGFR3 activating gene alterations, including locally advanced/metastatic urothelial carcinoma of the bladder and urinary tract and other advanced solid tumors.
Sponsor: Tyra Biosciences, Inc
Check if you qualify for this bladder cancer clinical trial in Nashville, TN
If you're searching for bladder cancer treatment options in Nashville, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.